Noyna, Amelita B.
HRN: 26-57-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/23/2025
CEFTRIAXONE 1G (VIAL)
01/23/2025
01/30/2025
IV
2grams
Once Daily
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes